Immediate Impact
4 hit
Citing Papers
Harnessing cytokines and chemokines for cancer therapy
2022 Hit
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
2021 Hit
Works of Richard Wnek being referenced
First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
2020
Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors
2020